18F-FDG-PET/CT in the assessment of pulmonary solitary nodules: Comparison of different analysis methods and risk variables in the prediction of malignancy

Translational Lung Cancer Research

Volumn 4, Issue 3, 2015, Pages 228-235

  López, Ober van Gómez ^a   Vicente, Ana María García ^a   Martínez, Antonio Francisco Honguero ^b   Londoño, Germán Andrés Jiménez ^a   Caicedo, Carlos Hugo Vega ^a   Atance, Pablo León ^b   Castrejón, Ángel María Soriano ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

Clinical variables; Diagnostic accuracy; Metabolic criteria; Positron emission tomography (PET); Solitary pulmonary nodule (SPN)

Indexed keywords

EID: 84947417758     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2015.05.07     Document Type: Article

References (27)

1. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722
2. Sim YT, Poon FW. Imaging of solitary pulmonary nodule-a clinical review. Quant Imaging Med Surg 2013;3:316-26
3. Chang CY, Tzao C, Lee SC, et al. Incremental value of integrated FDG-PET/CT in evaluating indeterminate solitary pulmonary nodule for malignancy. Mol Imaging Biol 2010;12:204-9
4. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:108S-130S
5. Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule. Chest 2003;123:89S-96S
6. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:94S-107S
7. Bogot NR, Shaham D. Semi-invasive and invasive procedures for the diagnosis and staging of lung cancer. II. Bronchoscopic and surgical procedures. Radiol Clin North Am 2000;38:535-44
8. Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S-120S
9. Nomori H, Watanabe K, Ohtsuka T, et al. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg 2005;79:984-8; discussion 989
10. Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmonary nodules: meta-analytic comparison of crosssectional imaging modalities for diagnosis of malignancy. Radiology 2008;246:772-82
11. Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007;48:214-20
12. Li Y, Wang J. A mathematical model for predicting malignancy of solitary pulmonary nodules. World J Surg 2012;36:830-5
13. Grgic A, Yüksel Y, Gröschel A, et al. Risk stratification of solitary pulmonary nodules by means of PET using (18) F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging 2010;37:1087-94
14. Herder GJ, van T interen H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-6
15. Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med 2008;49:1804-8
16. Gould MK, Ananth L, Barnett PG, et al. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;131:383-8
17. Hashimoto Y, Tsujikawa T, Kondo C, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006;47:426-31
18. Metser U, Even-Sapir E. Increased (18) F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/ CT. Semin Nucl Med 2007;37:206-22
19. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50 Suppl 1:11S-20S
20. Khalaf M, Abdel-Nabi H, Baker J, et al. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol 2008;1:13
21. Kim SC, Machac J, Krynyckyi BR, et al. Fluoro-deoxyglucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Ann Nucl Med 2008;22:165-70
22. García Vicente AM, Soriano Castrejón AM, Talavera Rubio MP, et al. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications. Ann Nucl Med 2010;24:207-14
23. García Vicente AM, Soriano Castrejón A, Talavera Rubio P, et al. (18)F-FDG PET-CT and respiratory synchronization: effect in the detection and catalogation of pulmonary lesions. Rev Esp Med Nucl 2009;28:181-7
24. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-8
25. Sachs S, Fiore JJ. An overview of lung cancer. Respir Care Clin N Am 2003;9:1-25
26. Wiener RS, Wiener DC, Gould MK. Risks of Transthoracic Needle Biopsy: How High? Clin Pulm Med 2013;20:29-35
27. van Rens MT, de la Rivière AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-9.